Free Trial

LadRx (CYTR) News Today

→ Are you prepared for a Chinese 'invasion?' (From Behind the Markets) (Ad)
Free CYTR Stock Alerts
Compare
Headlines
Stock Analysis
June 16 at 1:48 AM | americanbankingnews.com
Bio-Techne (NASDAQ:TECH) & LadRx (OTCMKTS:CYTR) Financial Contrast
May 17, 2024 | finance.yahoo.com
LadRx Corporation (LADX)
August 11, 2023 | finance.yahoo.com
LadRx Corporation (LADX) Stock Historical Prices & Data - Yahoo Finance
November 27, 2022 | finance.yahoo.com
LadRx Corporation Issues Corporate Update for 3Q22
October 5, 2022 | businesswire.com
LadRx Corporation Announces OTCQB Ticker Change to LADX - Business Wire
September 23, 2022 | marketscreener.com
CYTRX CORP : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) - Marketscreener.com
September 23, 2022 | businesswire.com
CytRx Corporation Relaunches as LadRx Corporation - Business Wire
September 7, 2022 | businesswire.com
European Patent Office Awards CytRx Key Patent - Business Wire
August 25, 2022 | marketscreener.com
ADIAL PHARMACEUTICALS, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K) - Marketscreener.com
August 21, 2022 | reuters.com
CYTR.PK - CytRx Corporation | Stock Price & Latest News | Reuters
August 9, 2022 | businesswire.com
CytRx Welcomes Cary J. Claiborne to the CytRx Board of Directors - Business Wire
August 9, 2022 | finance.yahoo.com
CytRx Welcomes Cary J. Claiborne to the CytRx Board of Directors
July 27, 2022 | marketscreener.com
CYTRX CORP : Submission of Matters to a Vote of Security Holders (form 8-K) - Marketscreener.com
May 20, 2022 | stockhouse.com
2022-05-19 | OTCQB:CYTR | Press Release | CytRx Corporation - Stockhouse
May 20, 2022 | businesswire.com
CytRx Announces Distribution of Series D Preferred Stock to Holders of Its Common Stock - Business Wire
May 20, 2022 | marketscreener.com
CYTRX CORP : Material Modification to Rights of Security Holders, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) - Marketscreener.com
May 19, 2022 | finance.yahoo.com
CytRx Announces Distribution of Series D Preferred Stock to Holders of Its Common Stock - Yahoo Finance
May 19, 2022 | marketscreener.com
CytRx Announces Distribution of Series D Preferred Stock to Holders of Its Common Stock - Marketscreener.com
May 17, 2022 | finance.yahoo.com
CytRx Highlights Strategic Purchase of Arimoclomol by KemPharm, Inc.
May 16, 2022 | streetinsider.com
Arcellx (ACLX) Appoints Olivia Ware to its Board - StreetInsider.com
April 20, 2022 | businesswire.com
CytRx Partners with Oncology Development Expert to Advance LADR Platform - Business Wire
April 20, 2022 | finance.yahoo.com
CytRx Partners with Oncology Development Expert to Advance LADR Platform
April 13, 2022 | prnewswire.com
Gene Therapies & Associated Vectors 2022: Intellectual Property Landscape, Patent Valuation Analysis, Granted Patents and Claims Analysis - PR Newswire
March 25, 2022 | streetinsider.com
Form 424B3 CYTRX CORP - StreetInsider.com
March 23, 2022 | benzinga.com
CytRx Issues Open Letter to Stockholders Regarding Recent Corporate Progress - Benzinga - Benzinga
March 23, 2022 | marketscreener.com
CYTRX CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K) - Marketscreener.com
March 21, 2022 | finance.yahoo.com
CytRx Issues Open Letter to Stockholders Regarding Recent Corporate Progress - Yahoo Finance
March 21, 2022 | finance.yahoo.com
CytRx Issues Open Letter to Stockholders Regarding Recent Corporate Progress
March 12, 2022 | uk.investing.com
Orphazyme Calls For Court-Mediated Restructuring, Lays Off 50% Workforce By Benzinga - Investing.com UK
March 11, 2022 | benzinga.com
Orphazyme Calls For Court-Mediated Restructuring, Lays Off 50% Workforce - Benzinga - Benzinga
March 10, 2022 | businesswire.com
CytRx Announces Integration of Wholly Owned Subsidiary Centurion BioPharma and Corporate Governance Updates - Business Wire
March 9, 2022 | seekingalpha.com
CytRx to absorb subsidiary Centurion BioPharma; former CEO retires from board
March 9, 2022 | finance.yahoo.com
CytRx Announces Integration of Wholly Owned Subsidiary Centurion BioPharma and Corporate Governance Updates - Yahoo Finance
February 26, 2022 | marketscreener.com
Investor Presentation: February 2022 - marketscreener.com
February 24, 2022 | nasdaq.com
Health Care Sector Update for 02/24/2022: ORPH,CYTR,FEMY,CLRB,EVH,LNTH - Nasdaq
February 24, 2022 | finance.yahoo.com
CytRx Comments on Orphazyme's Update on European Union Regulatory Review of Arimoclomol in Niemann-Pick Disease Type C
February 17, 2022 | marketscreener.com
CytRx : FAQ on Issuance of Shares to Armistice Capital and Special Meeting of Shareholders to Approve Increase in Authorized Shares - Form 8-K - marketscreener.com
February 14, 2022 | businesswire.com
CytRx Highlights Orphazyme's Update on Planned NDA Resubmission for Arimoclomol in Niemann-Pick Disease Type C - Business Wire
February 14, 2022 | finance.yahoo.com
CytRx Highlights Orphazyme's Update on Planned NDA Resubmission for Arimoclomol in Niemann-Pick Disease Type C
February 11, 2022 | seekingalpha.com
Orphazyme gains on plans to resubmit U.S. marketing application for arimoclomol - Seeking Alpha
January 26, 2022 | marketscreener.com
CYTRX CORP : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) - marketscreener.com
January 26, 2022 | marketscreener.com
CytRx : Shareholder Letter, mailed on January 25, 2022 (furnished herewith pursuant to Item 7.01) - Form 8-K - marketscreener.com
January 18, 2022 | finance.yahoo.com
CytRx to Hold Town Hall for Stockholders on Thursday, January 20th
January 7, 2022 | marketscreener.com
CytRx to Participate in the H.C. Wainwright BioConnect Virtual Conference - marketscreener.com
January 5, 2022 | uk.finance.yahoo.com
Oculis appoints Mr. Webb Ding as Global Chief Operating Officer and General Manager (China) - Yahoo Finance UK
January 4, 2022 | marketscreener.com
CytRx : Announces the Appointment of Dr. Stephen Snowdy as Chief Executive Officer - Form 8-K - marketscreener.com
January 4, 2022 | marketscreener.com
CYTRX CORP : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) - marketscreener.com
January 3, 2022 | businesswire.com
CytRx Announces the Appointment of Dr. Stephen Snowdy as Chief Executive Officer - Business Wire
January 3, 2022 | finance.yahoo.com
CytRx Announces the Appointment of Dr. Stephen Snowdy as Chief Executive Officer
December 28, 2021 | seekingalpha.com
ImmunityBio pares gains following aldoxorubicin data in cancer - Seeking Alpha
Get LadRx News Delivered to You Automatically

Sign up to receive the latest news and ratings for CYTR and its competitors with MarketBeat's FREE daily newsletter.

The attacks will come for me after releasing this… (Ad)

America’s “Internal Enemies” Exposed New documentary exposes a hidden election plan in Washington D.C. that, if successful, could be more financially and culturally devastating than the dot-com blowup of 2000, the 2008 financial crisis, or the COVID crash.

Click here to see how you can protect yourself today.

CYTR Media Mentions By Week

CYTR Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CYTR
News Sentiment
▼
0.00

0.91
▲
Average
Medical
News Sentiment

CYTR News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CYTR Articles
This Week
▼
1

0
▲
CYTR Articles
Average Week

Get LadRx News Delivered to You Automatically

Sign up to receive the latest news and ratings for CYTR and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (OTCMKTS:CYTR) was last updated on 6/18/2024 by MarketBeat.com Staff

From Our Partners
AI's Next Magnificent Seven
The Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.
The Oxford Club | Sponsored
Biden to Launch “FedNOW” [Move Your Money Now]
Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...
Priority Gold | Sponsored
Bigger Than NVIDIA?
With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...
Behind the Markets | Sponsored
Beta testers blew this thing up
This AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and fi...
Prosper Trading Academy | Sponsored
Radical change coming — do this NOW to protect yourself
I recently uncovered a way the government could use the next crisis as a pretext to gain more control … and ra...
Weiss Ratings | Sponsored
The #1 Crypto That You Don’t Own… Yet
There’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...
Crypto 101 Media | Sponsored
Breaking News: Elon Musk Invents New Type of A.I. (Shocking)
Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...
InvestorPlace | Sponsored
Kiss of death from Joe Biden
I did not consent. You did not consent. It’s in direct violation of the U.S. Constitution but Biden does ...
Porter & Company | Sponsored